Intratympanic steroid for Bell's palsy. Single-centre randomized controlled trial.

Not Applicable

• Conditions: s palsy; Bell&#39

• Registration Number: JPRN-UMIN000024313
• Lead Sponsor: Kurashiki Central Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-07
• Study Completion: 2018-09-08
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

Not provided

Exclusion Criteria

Pregnancy, breast-Feeding. dementia and difficult to enroll trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
on-recovery rate(House-Brackmann grade 3 or more) at 6 month after disease onset. We define recovery as House-Brackmann grade 1-2. Primary outcome will be measured by blinded assesser.

Secondary Outcome Measures

Name	Time	Method
on-recovery rate at last follow up (6 to 12 month after disease onset) Tympanic membrane perforation and any complications during intratympanic injection (e.g. vertigo, vomiting, and vasovagal syncope)